The potential cost-effectiveness of adding a human papillomavirus vaccine to the cervical cancer screening programme in South Africa.
about
Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspectiveChallenges in Cost-Effectiveness Analysis Modelling of HPV Vaccines in Low- and Middle-Income Countries: A Systematic Review and Practice Recommendations.Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models.Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analystsCost-effectiveness analysis of human papillomavirus vaccination in South Africa accounting for human immunodeficiency virus prevalence.Cost-Effectiveness of Screening and Treatment for Cervical Cancer in Tanzania: Implications for other Sub-Saharan African Countries.The cost effectiveness of human papillomavirus vaccines: a systematic review.Human papillomavirus vaccines: where do they fit in HIV-infected individuals?The state of health economic research in South Africa: a systematic review.Modelling the cost-effectiveness of a new infant vaccine to prevent tuberculosis disease in children in South AfricaCost-effectiveness of Human Papilloma Virus (HPV) vaccination in Nigeria: a decision analysis using pragmatic parameter estimates for cost and programme coverage.Cost effectiveness of human papilloma virus vaccination in low and middle income countries: a systematic review of literature.The Price of Prevention: Cost Effectiveness of Biomedical HIV Prevention Strategies in South Africa
P2860
Q28601706-F98F4560-A61B-4A3E-9C9B-9F33BE481DB6Q30245295-614F5567-1FD3-4703-BC0F-F967D2A4F304Q33898840-17189B08-5384-4D40-9AAD-5708F8B07A34Q34567701-10A6C0E4-B14F-438D-AF14-A96B8A8F6A7EQ35865134-1DCD3C37-DA3F-41AD-A943-FA53B9E165FBQ37440689-2F907BC4-7E91-431A-968B-3678B5CE50C8Q37993109-485CE75E-4D18-46A4-8EDF-7260BA5A9D37Q38022478-8A94B978-9D34-47F8-A4DA-047E70C55F5EQ38027235-1C2464D3-60E3-42CB-A6B2-2D46E18465D9Q39125505-296C2944-8859-4D4F-89E4-54C2C0DAA9B6Q45323637-FAF768D8-C181-446B-BDC4-E413C76D2B17Q45324144-02298C98-2419-4F73-8CCC-6EB201338616Q56910975-60F94571-7193-4324-9DA8-0DB2704479EB
P2860
The potential cost-effectiveness of adding a human papillomavirus vaccine to the cervical cancer screening programme in South Africa.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
The potential cost-effectivene ...... ing programme in South Africa.
@en
The potential cost-effectivene ...... ing programme in South Africa.
@nl
type
label
The potential cost-effectivene ...... ing programme in South Africa.
@en
The potential cost-effectivene ...... ing programme in South Africa.
@nl
prefLabel
The potential cost-effectivene ...... ing programme in South Africa.
@en
The potential cost-effectivene ...... ing programme in South Africa.
@nl
P2093
P1433
P1476
The potential cost-effectivene ...... ing programme in South Africa.
@en
P2093
Edina Sinanovic
Jane Harries
Jennifer Moodley
Mark A Barone
Sumaya Mall
Susan Cleary
P304
P356
10.1016/J.VACCINE.2009.08.004
P407
P577
2009-08-19T00:00:00Z